InMed Pharmaceuticals Inc. Annual Share-based Payment Arrangement, Expense in USD from 2020 to 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
Summary
InMed Pharmaceuticals Inc. quarterly/annual Share-based Payment Arrangement, Expense history and growth rate from 2020 to 2024.
  • InMed Pharmaceuticals Inc. Share-based Payment Arrangement, Expense for the quarter ending September 30, 2024 was $29K, a 15% increase year-over-year.
  • InMed Pharmaceuticals Inc. annual Share-based Payment Arrangement, Expense for 2024 was $138K, a 50.5% decline from 2023.
  • InMed Pharmaceuticals Inc. annual Share-based Payment Arrangement, Expense for 2023 was $278K, a 60.1% decline from 2022.
  • InMed Pharmaceuticals Inc. annual Share-based Payment Arrangement, Expense for 2022 was $698K, a 14.4% increase from 2021.
Share-based Payment Arrangement, Expense, Trailing 12 Months (USD)
Share-based Payment Arrangement, Expense, Annual (USD)
Share-based Payment Arrangement, Expense, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2024 $138K -$140K -50.5% Jul 1, 2023 Jun 30, 2024 10-K 2024-09-30
2023 $278K -$420K -60.1% Jul 1, 2022 Jun 30, 2023 10-K 2024-09-30
2022 $698K +$87.7K +14.4% Jul 1, 2021 Jun 30, 2022 10-K 2023-09-29
2021 $610K -$384K -38.6% Jul 1, 2020 Jun 30, 2021 10-K 2022-09-23
2020 $994K Jul 1, 2019 Jun 30, 2020 10-K 2021-09-24
* An asterisk sign (*) next to the value indicates that the value is likely invalid.